On September 21, 2021, Joel Dube notified Vapotherm, Inc. of his decision to resign as Chief Accounting Officer of the Company effective October 6, 2021 in order to pursue other career opportunities. Mr. Dube’s decision to leave the Company is not a result of any disagreement with the Company’s independent auditors or any member of management on any matter of accounting principles or practices, financial statement disclosure or internal controls. In connection with Mr. Dube’s resignation, John Landry, the Company’s Senior Vice President and Chief Financial Officer, will assume Mr. Dube’s duties as principal accounting officer in addition to continuing to serve as Chief Financial Officer.
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.
VAPOTHERM, INC. 
